ÂÜÀòÂÒÂ×

Sandra Carbonneau is a seasoned professional in the biopharmaceutical and contract development manufacturing sectors, currently serving as Senior Director of Business Development at AGC Biologics since January 2024. With a robust background, Sandra has held senior roles at Curia and WuXi Biologics, where leadership in business development was key in navigating acquisitions and expansions. Prior positions include Director of Business Development at Avid Bioservices and IPS, contributing to technical consulting and contract manufacturing. Sandra's extensive tenure at Lonza as Director of Commercial Development solidified expertise in operations, quality compliance, and strategic alliances. Sandra began a career in manufacturing at Repligen Corporation and holds a Bachelor's degree in Biology from the University of Massachusetts Lowell.